CD274 and adenocarcinoma: PD-L1 was positive in 50.0% of all cases of adenocarcinomas, which is significantly higher compared to findings of Reddy et al. which was 7%, Heeren et al. which was 14% and Saglam et al. which was 17% [16,17,28].